You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-GPR52 antagonist E7
GPR52 antagonist E7

Chemical Structure : GPR52 antagonist E7

CAS No.: 2305684-39-1

GPR52 antagonist E7 (AD31E7)

Catalog No.: PC-72129Not For Human Use, Lab Use Only.

GPR52 antagonist E7 is a novel Gpr52 antagonist, shows significant inhibitory effect on WO-459 (100 nM)-induced cAMP elevation in HEK293/GPR52 cells with IC50 of 12.0 uM.

Packing Price Stock Quantity
25 mg Get quote
100 mg Get quote
250 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

GPR52 antagonist E7 is a novel Gpr52 antagonist, shows significant inhibitory effect on WO-459 (100 nM)-induced cAMP elevation in HEK293/GPR52 cells with IC50 of 12.0 uM.
GPR52 antagonist E7 did not block cAMP elevation induced by Gαs-coupled GPCRs, including β2AR, GCGR and GLP-1R.
GPR52 antagonist E7 reduces mutant HTT levels and rescues Huntington's disease-associated phenotypes in cellular and mouse models.
GPR52 antagonist E7 acts as an tntracellular covalent ligand of orphan receptor GPR52.

Physicochemical Properties

M.Wt 358.39
Formula C20H22O6
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Month
Shipping
Solubility

Chemical Name/SMILES

References

1. Song H, et al. Brain. 2018 Jun 1;141(6):1782-1798.

2. Ma M, et al. ACS Chem Biol. 2020 Dec 18;15(12):3275-3284.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: